These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 20805522)

  • 21. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral blood flow in presymptomatic MAPT and GRN mutation carriers: A longitudinal arterial spin labeling study.
    Dopper EG; Chalos V; Ghariq E; den Heijer T; Hafkemeijer A; Jiskoot LC; de Koning I; Seelaar H; van Minkelen R; van Osch MJ; Rombouts SA; van Swieten JC
    Neuroimage Clin; 2016; 12():460-5. PubMed ID: 27625986
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rates of Brain Atrophy Across Disease Stages in Familial Frontotemporal Dementia Associated With MAPT, GRN, and C9orf72 Pathogenic Variants.
    Staffaroni AM; Goh SM; Cobigo Y; Ong E; Lee SE; Casaletto KB; Wolf A; Forsberg LK; Ghoshal N; Graff-Radford NR; Grossman M; Heuer HW; Hsiung GR; Kantarci K; Knopman DS; Kremers WK; Mackenzie IR; Miller BL; Pedraza O; Rascovsky K; Tartaglia MC; Wszolek ZK; Kramer JH; Kornak J; Boeve BF; Boxer AL; Rosen HJ;
    JAMA Netw Open; 2020 Oct; 3(10):e2022847. PubMed ID: 33112398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
    Voevodskaya O; Poulakis K; Sundgren P; van Westen D; Palmqvist S; Wahlund LO; Stomrud E; Hansson O; Westman E;
    Neurology; 2019 Jan; 92(5):e395-e405. PubMed ID: 30610093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frontotemporal dementia with the V337M
    Spina S; Schonhaut DR; Boeve BF; Seeley WW; Ossenkoppele R; O'Neil JP; Lazaris A; Rosen HJ; Boxer AL; Perry DC; Miller BL; Dickson DW; Parisi JE; Jagust WJ; Murray ME; Rabinovici GD
    Neurology; 2017 Feb; 88(8):758-766. PubMed ID: 28130473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
    Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
    Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies.
    Forrest SL; Kril JJ; Stevens CH; Kwok JB; Hallupp M; Kim WS; Huang Y; McGinley CV; Werka H; Kiernan MC; Götz J; Spillantini MG; Hodges JR; Ittner LM; Halliday GM
    Brain; 2018 Feb; 141(2):521-534. PubMed ID: 29253099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: a GENFI study.
    Mutsaerts HJMM; Mirza SS; Petr J; Thomas DL; Cash DM; Bocchetta M; de Vita E; Metcalfe AWS; Shirzadi Z; Robertson AD; Tartaglia MC; Mitchell SB; Black SE; Freedman M; Tang-Wai D; Keren R; Rogaeva E; van Swieten J; Laforce R; Tagliavini F; Borroni B; Galimberti D; Rowe JB; Graff C; Frisoni GB; Finger E; Sorbi S; de Mendonça A; Rohrer JD; MacIntosh BJ; Masellis M;
    Brain; 2019 Apr; 142(4):1108-1120. PubMed ID: 30847466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy.
    Ferrer I; Andrés-Benito P; Zelaya MV; Aguirre MEE; Carmona M; Ausín K; Lachén-Montes M; Fernández-Irigoyen J; Santamaría E; Del Rio JA
    Acta Neuropathol; 2020 Apr; 139(4):735-771. PubMed ID: 31907603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Volumetric MRI and 1H MRS study of hippocampus in unilateral MCAO patients: relationship between hippocampal secondary damage and cognitive disorder following stroke.
    Tang X; Wang C; Xia L; Zhu W; Zhao L; Zhu W
    Eur J Radiol; 2012 Oct; 81(10):2788-93. PubMed ID: 21945401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies.
    Graff-Radford J; Boeve BF; Murray ME; Ferman TJ; Tosakulwong N; Lesnick TG; Maroney-Smith M; Senjem ML; Gunter J; Smith GE; Knopman DS; Jack CR; Dickson DW; Petersen RC; Kantarci K
    Neurobiol Aging; 2014 Jun; 35(6):1483-90. PubMed ID: 24468473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathologic heterogeneity in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) due to microtubule-associated protein tau (MAPT) p.P301L mutation, including a patient with globular glial tauopathy.
    Tacik P; Sanchez-Contreras M; DeTure M; Murray ME; Rademakers R; Ross OA; Wszolek ZK; Parisi JE; Knopman DS; Petersen RC; Dickson DW
    Neuropathol Appl Neurobiol; 2017 Apr; 43(3):200-214. PubMed ID: 27859539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. (1)H-MRS metabolites in adults with Down syndrome: Effects of dementia.
    Lin AL; Powell D; Caban-Holt A; Jicha G; Robertson W; Gold BT; Davis R; Abner E; Wilcock DM; Schmitt FA; Head E
    Neuroimage Clin; 2016; 11():728-735. PubMed ID: 27330972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers.
    Chen Q; Boeve BF; Schwarz CG; Reid R; Tosakulwong N; Lesnick TG; Bove J; Brannelly P; Brushaber D; Coppola G; Dheel C; Dickerson BC; Dickinson S; Faber K; Fields J; Fong J; Foroud T; Forsberg L; Gavrilova RH; Gearhart D; Ghoshal N; Goldman J; Graff-Radford J; Graff-Radford NR; Grossman M; Haley D; Heuer HW; Hsiung GR; Huey E; Irwin DJ; Jack CR; Jones DT; Jones L; Karydas AM; Knopman DS; Kornak J; Kramer J; Kremers W; Kukull WA; Lapid M; Lucente D; Lungu C; Mackenzie IRA; Manoochehri M; McGinnis S; Miller BL; Pearlman R; Petrucelli L; Potter M; Rademakers R; Ramos EM; Rankin KP; Rascovsky K; Sengdy P; Shaw L; Syrjanen J; Tatton N; Taylor J; Toga AW; Trojanowski J; Weintraub S; Wong B; Boxer AL; Rosen H; Wszolek Z; Kantarci K;
    Neurobiol Aging; 2019 Nov; 83():54-62. PubMed ID: 31585367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel tau mutation, p.K317N, causes globular glial tauopathy.
    Tacik P; DeTure M; Lin WL; Sanchez Contreras M; Wojtas A; Hinkle KM; Fujioka S; Baker MC; Walton RL; Carlomagno Y; Brown PH; Strongosky AJ; Kouri N; Murray ME; Petrucelli L; Josephs KA; Rademakers R; Ross OA; Wszolek ZK; Dickson DW
    Acta Neuropathol; 2015 Aug; 130(2):199-214. PubMed ID: 25900293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting.
    Almuqbel M; Melzer TR; Myall DJ; MacAskill MR; Pitcher TL; Livingston L; Wood KL; Keenan RJ; Dalrymple-Alford JC; Anderson TJ
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26627939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
    Heller C; Foiani MS; Moore K; Convery R; Bocchetta M; Neason M; Cash DM; Thomas D; Greaves CV; Woollacott IO; Shafei R; Van Swieten JC; Moreno F; Sanchez-Valle R; Borroni B; Laforce R; Masellis M; Tartaglia MC; Graff C; Galimberti D; Rowe JB; Finger E; Synofzik M; Vandenberghe R; de Mendonca A; Tagliavini F; Santana I; Ducharme S; Butler CR; Gerhard A; Levin J; Danek A; Frisoni G; Sorbi S; Otto M; Heslegrave AJ; Zetterberg H; Rohrer JD;
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):263-270. PubMed ID: 31937580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales.
    Fumagalli GG; Basilico P; Arighi A; Bocchetta M; Dick KM; Cash DM; Harding S; Mercurio M; Fenoglio C; Pietroboni AM; Ghezzi L; van Swieten J; Borroni B; de Mendonça A; Masellis M; Tartaglia MC; Rowe JB; Graff C; Tagliavini F; Frisoni GB; Laforce R; Finger E; Sorbi S; Scarpini E; Rohrer JD; Galimberti D;
    Alzheimers Res Ther; 2018 May; 10(1):46. PubMed ID: 29793546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.